Research activities of «Grindeks» are mainly focused towards the development of:
– cardiovascular medications;
– neurological medications;
– anti-cancer agents;
– antivirual drugs.
and organisation of biomedical pre-clinical trials are performed in the
field of the development of new products. In cooperation with the
leading scientific research institutions from Latvia and abroad active
work is carried out in the development of several new medications.
Every year 4–5 research projects are carried out in the company.
Head of the New Product Development department